| - SMTL ID
- 3m6g.1
- Ligands
- MAGNESIUM ION; ADENOSINE-5'-TRIPHOSPHATE; (1S,3S,4S,5S,7R,8S,9R,12E,14E,16R,17R,19R)-16-hydroxy-9-{(1S,2S,3S)-2-hydroxy-5-[(2S,4R,6S)-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl]-1,3-dimethylpentyl}-3,5,7,17-tetramethoxy-8,14-dimethyl-11H-spiro[10,23-dioxabicyclo[17.3.1]tricosa-12,14,20-triene-4,2'-oxiran]-11-one; CALCIUM ION
- Polypeptides
- Actin, alpha skeletal muscle
- Oligo-state
- homo-dimer
|
| - SMTL ID
- 3m6g.2
- Ligands
- MAGNESIUM ION; ADENOSINE-5'-TRIPHOSPHATE; (1S,3S,4S,5S,7R,8S,9R,12E,14E,16R,17R,19R)-16-hydroxy-9-{(1S,2S,3S)-2-hydroxy-5-[(2S,4R,6S)-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl]-1,3-dimethylpentyl}-3,5,7,17-tetramethoxy-8,14-dimethyl-11H-spiro[10,23-dioxabicyclo[17.3.1]tricosa-12,14,20-triene-4,2'-oxiran]-11-one; CALCIUM ION
- Polypeptides
- Actin, alpha skeletal muscle
- Oligo-state
- monomer
|
| - SMTL ID
- 3m6g.3
- Ligands
- MAGNESIUM ION; ADENOSINE-5'-TRIPHOSPHATE; (1S,3S,4S,5S,7R,8S,9R,12E,14E,16R,17R,19R)-16-hydroxy-9-{(1S,2S,3S)-2-hydroxy-5-[(2S,4R,6S)-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl]-1,3-dimethylpentyl}-3,5,7,17-tetramethoxy-8,14-dimethyl-11H-spiro[10,23-dioxabicyclo[17.3.1]tricosa-12,14,20-triene-4,2'-oxiran]-11-one; CALCIUM ION
- Polypeptides
- Actin, alpha skeletal muscle
- Oligo-state
- monomer
|